This document focuses on how the Signals Research Suite supports emerging biological and chemical modalities, including complex biologics and next-generation therapeutics. It highlights the need for flexible, cloud-based SaaS platforms that can handle heterogeneous data, evolving workflows, and multidisciplinary collaboration. The suite integrates electronic lab notebooks, data processing, and analytics to provide a unified system of record across chemistry and biology. Built-in intelligence, standardized templates, and advanced visualization tools enable researchers to analyze relationships between structure, activity, and outcomes more efficiently. The platform reduces data silos, supports FAIR data principles, and accelerates innovation by enabling teams to collaborate and adapt quickly

Join for free to read